Which has higher earnings & valuation, TELA or OWLT?

TELA Bio has higher earnings, but lower revenue than Owlet. Owlet is trading at a lower price-to-earnings ratio than TELA Bio, indicating that it is currently the more affordable of the two stocks. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio TELA Bio $80.81M 0.48 -$38.83M -$0.79 N/A Owlet $107.06M 1.48 -$39.68M -$3.07 N/A

Is TELA or OWLT more profitable?

Owlet has a net margin of -42.54% compared to TELA Bio's net margin of -49.30%. Owlet's return on equity of 0.00% beat TELA Bio's return on equity. Company Net Margins Return on Equity Return on Assets TELA Bio -49.30% -1,320.81% -55.83% Owlet -42.54% N/A -18.02%

Does the media refer more to TELA or OWLT?

In the previous week, TELA Bio had 3 more articles in the media than Owlet. MarketBeat recorded 5 mentions for TELA Bio and 2 mentions for Owlet. TELA Bio's average media sentiment score of 0.46 beat Owlet's score of 0.00 indicating that TELA Bio is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment TELA Bio 1 Very Positive mention(s) 1 Positive mention(s) 3 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral Owlet 0 Very Positive mention(s) 0 Positive mention(s) 2 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral

Is TELA or STIM more profitable?

Neuronetics has a net margin of -24.48% compared to TELA Bio's net margin of -49.30%. Neuronetics' return on equity of -139.83% beat TELA Bio's return on equity. Company Net Margins Return on Equity Return on Assets TELA Bio -49.30% -1,320.81% -55.83% Neuronetics -24.48% -139.83% -27.13%

Does the media prefer TELA or STIM?

In the previous week, TELA Bio had 2 more articles in the media than Neuronetics. MarketBeat recorded 5 mentions for TELA Bio and 3 mentions for Neuronetics. TELA Bio's average media sentiment score of 0.46 beat Neuronetics' score of 0.03 indicating that TELA Bio is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment TELA Bio 1 Very Positive mention(s) 1 Positive mention(s) 3 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral Neuronetics 0 Very Positive mention(s) 1 Positive mention(s) 2 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral

Which has stronger valuation and earnings, TELA or CVRX?

TELA Bio has higher revenue and earnings than CVRx. CVRx is trading at a lower price-to-earnings ratio than TELA Bio, indicating that it is currently the more affordable of the two stocks. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio TELA Bio $80.81M 0.48 -$38.83M -$0.79 N/A CVRx $59.07M 2.67 -$53.31M -$2.02 N/A

Is TELA or CVRX more profitable?

TELA Bio has a net margin of -49.30% compared to CVRx's net margin of -89.14%. CVRx's return on equity of -120.76% beat TELA Bio's return on equity. Company Net Margins Return on Equity Return on Assets TELA Bio -49.30% -1,320.81% -55.83% CVRx -89.14% -120.76% -48.38%

Does the media prefer TELA or CVRX?

In the previous week, TELA Bio had 3 more articles in the media than CVRx. MarketBeat recorded 5 mentions for TELA Bio and 2 mentions for CVRx. TELA Bio's average media sentiment score of 0.46 beat CVRx's score of 0.00 indicating that TELA Bio is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment TELA Bio 1 Very Positive mention(s) 1 Positive mention(s) 3 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral CVRx 0 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral

Which has higher earnings and valuation, RCEL or TELA?

TELA Bio has higher revenue and earnings than Avita Medical. Avita Medical is trading at a lower price-to-earnings ratio than TELA Bio, indicating that it is currently the more affordable of the two stocks. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio Avita Medical $72.35M 2.02 -$48.59M -$1.57 N/A TELA Bio $80.81M 0.48 -$38.83M -$0.79 N/A

Is RCEL or TELA more profitable?

TELA Bio has a net margin of -49.30% compared to Avita Medical's net margin of -62.67%. Avita Medical's return on equity of 0.00% beat TELA Bio's return on equity. Company Net Margins Return on Equity Return on Assets Avita Medical -62.67% N/A -78.92% TELA Bio -49.30% -1,320.81% -55.83%

Does the media favor RCEL or TELA?

In the previous week, TELA Bio had 1 more articles in the media than Avita Medical. MarketBeat recorded 5 mentions for TELA Bio and 4 mentions for Avita Medical. TELA Bio's average media sentiment score of 0.46 beat Avita Medical's score of 0.00 indicating that TELA Bio is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Avita Medical 0 Very Positive mention(s) 0 Positive mention(s) 3 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral TELA Bio 1 Very Positive mention(s) 1 Positive mention(s) 3 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral

Is TELA or MBOT more profitable?

Microbot Medical has a net margin of 0.00% compared to TELA Bio's net margin of -49.30%. Microbot Medical's return on equity of -21.84% beat TELA Bio's return on equity. Company Net Margins Return on Equity Return on Assets TELA Bio -49.30% -1,320.81% -55.83% Microbot Medical N/A -21.84% -20.71%

Does the media refer more to TELA or MBOT?

In the previous week, TELA Bio had 3 more articles in the media than Microbot Medical. MarketBeat recorded 5 mentions for TELA Bio and 2 mentions for Microbot Medical. Microbot Medical's average media sentiment score of 0.52 beat TELA Bio's score of 0.46 indicating that Microbot Medical is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment TELA Bio 1 Very Positive mention(s) 1 Positive mention(s) 3 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral Microbot Medical 1 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive

TELA Bio (TELA) Competitors

$0.86 -0.06 (-6.01%)

Closing price 04:00 PM Eastern

Extended Trading

$0.86 0.00 (0.00%)

As of 04:10 PM Eastern

Compare

TELA vs. OWLT, STIM, CVRX, RCEL, and MBOT

Should you buy TELA Bio stock or one of its competitors? MarketBeat compares TELA Bio with other companies and stocks that may be similar based on industry, sector, market capitalization, business model, investor interest, or shared news coverage. Companies and stocks commonly compared with TELA Bio include Owlet (OWLT), Neuronetics (STIM), CVRx (CVRX), Avita Medical (RCEL), and Microbot Medical (MBOT). These companies are all part of the "healthcare equipment" industry.

How does TELA Bio compare to Owlet?

TELA Bio (NASDAQ:TELA) and Owlet (NYSE:OWLT) are both small-cap healthcare companies, but which is the better stock? We will compare the two companies based on the strength of their institutional ownership, profitability, earnings, dividends, media sentiment, valuation, risk and analyst recommendations.

94.3% of TELA Bio shares are owned by institutional investors. Comparatively, 72.6% of Owlet shares are owned by institutional investors. 5.1% of TELA Bio shares are owned by company insiders. Comparatively, 36.2% of Owlet shares are owned by company insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a stock will outperform the market over the long term.

Owlet has a net margin of -42.54% compared to TELA Bio's net margin of -49.30%. Owlet's return on equity of 0.00% beat TELA Bio's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
TELA Bio	-49.30%	-1,320.81%	-55.83%
Owlet	-42.54%	N/A	-18.02%

In the previous week, TELA Bio had 3 more articles in the media than Owlet. MarketBeat recorded 5 mentions for TELA Bio and 2 mentions for Owlet. TELA Bio's average media sentiment score of 0.46 beat Owlet's score of 0.00 indicating that TELA Bio is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
TELA Bio	1 Very Positive mention(s)	1 Positive mention(s)	3 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral
Owlet	0 Very Positive mention(s)	0 Positive mention(s)	2 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral

TELA Bio has a beta of 1.34, suggesting that its stock price is 34% more volatile than the broader market. Comparatively, Owlet has a beta of 1.85, suggesting that its stock price is 85% more volatile than the broader market.

TELA Bio presently has a consensus target price of $2.20, indicating a potential upside of 155.81%. Owlet has a consensus target price of $15.00, indicating a potential upside of 175.84%. Given Owlet's higher possible upside, analysts plainly believe Owlet is more favorable than TELA Bio.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
TELA Bio	1 Sell rating(s)	1 Hold rating(s)	3 Buy rating(s)	0 Strong Buy rating(s)	2.40
Owlet	1 Sell rating(s)	1 Hold rating(s)	3 Buy rating(s)	0 Strong Buy rating(s)	2.40

TELA Bio has higher earnings, but lower revenue than Owlet. Owlet is trading at a lower price-to-earnings ratio than TELA Bio, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
TELA Bio	$80.81M	0.48	-$38.83M	-$0.79	N/A
Owlet	$107.06M	1.48	-$39.68M	-$3.07	N/A

Summary

Owlet beats TELA Bio on 8 of the 14 factors compared between the two stocks.

How does TELA Bio compare to Neuronetics?

TELA Bio (NASDAQ:TELA) and Neuronetics (NASDAQ:STIM) are both small-cap healthcare companies, but which is the superior business? We will contrast the two businesses based on the strength of their institutional ownership, profitability, media sentiment, earnings, risk, dividends, valuation and analyst recommendations.

TELA Bio has a beta of 1.34, suggesting that its share price is 34% more volatile than the broader market. Comparatively, Neuronetics has a beta of 1.03, suggesting that its share price is 3% more volatile than the broader market.

TELA Bio has higher earnings, but lower revenue than Neuronetics. Neuronetics is trading at a lower price-to-earnings ratio than TELA Bio, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
TELA Bio	$80.81M	0.48	-$38.83M	-$0.79	N/A
Neuronetics	$151.64M	1.03	-$39M	-$0.54	N/A

In the previous week, TELA Bio had 2 more articles in the media than Neuronetics. MarketBeat recorded 5 mentions for TELA Bio and 3 mentions for Neuronetics. TELA Bio's average media sentiment score of 0.46 beat Neuronetics' score of 0.03 indicating that TELA Bio is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
TELA Bio	1 Very Positive mention(s)	1 Positive mention(s)	3 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral
Neuronetics	0 Very Positive mention(s)	1 Positive mention(s)	2 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral

Neuronetics has a net margin of -24.48% compared to TELA Bio's net margin of -49.30%. Neuronetics' return on equity of -139.83% beat TELA Bio's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
TELA Bio	-49.30%	-1,320.81%	-55.83%
Neuronetics	-24.48%	-139.83%	-27.13%

94.3% of TELA Bio shares are owned by institutional investors. Comparatively, 53.6% of Neuronetics shares are owned by institutional investors. 5.1% of TELA Bio shares are owned by insiders. Comparatively, 8.4% of Neuronetics shares are owned by insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a company is poised for long-term growth.

TELA Bio currently has a consensus price target of $2.20, indicating a potential upside of 155.81%. Neuronetics has a consensus price target of $4.00, indicating a potential upside of 77.78%. Given TELA Bio's higher possible upside, equities research analysts plainly believe TELA Bio is more favorable than Neuronetics.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
TELA Bio	1 Sell rating(s)	1 Hold rating(s)	3 Buy rating(s)	0 Strong Buy rating(s)	2.40
Neuronetics	1 Sell rating(s)	0 Hold rating(s)	3 Buy rating(s)	0 Strong Buy rating(s)	2.50

Summary

Neuronetics beats TELA Bio on 8 of the 15 factors compared between the two stocks.

How does TELA Bio compare to CVRx?

TELA Bio (NASDAQ:TELA) and CVRx (NASDAQ:CVRX) are both small-cap healthcare companies, but which is the superior investment? We will contrast the two businesses based on the strength of their profitability, institutional ownership, valuation, earnings, dividends, media sentiment, risk and analyst recommendations.

TELA Bio currently has a consensus target price of $2.20, indicating a potential upside of 155.81%. CVRx has a consensus target price of $11.50, indicating a potential upside of 93.60%. Given TELA Bio's higher probable upside, research analysts clearly believe TELA Bio is more favorable than CVRx.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
TELA Bio	1 Sell rating(s)	1 Hold rating(s)	3 Buy rating(s)	0 Strong Buy rating(s)	2.40
CVRx	1 Sell rating(s)	0 Hold rating(s)	1 Buy rating(s)	1 Strong Buy rating(s)	2.67

TELA Bio has higher revenue and earnings than CVRx. CVRx is trading at a lower price-to-earnings ratio than TELA Bio, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
TELA Bio	$80.81M	0.48	-$38.83M	-$0.79	N/A
CVRx	$59.07M	2.67	-$53.31M	-$2.02	N/A

In the previous week, TELA Bio had 3 more articles in the media than CVRx. MarketBeat recorded 5 mentions for TELA Bio and 2 mentions for CVRx. TELA Bio's average media sentiment score of 0.46 beat CVRx's score of 0.00 indicating that TELA Bio is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
TELA Bio	1 Very Positive mention(s)	1 Positive mention(s)	3 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral
CVRx	0 Very Positive mention(s)	0 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral

TELA Bio has a net margin of -49.30% compared to CVRx's net margin of -89.14%. CVRx's return on equity of -120.76% beat TELA Bio's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
TELA Bio	-49.30%	-1,320.81%	-55.83%
CVRx	-89.14%	-120.76%	-48.38%

TELA Bio has a beta of 1.34, suggesting that its share price is 34% more volatile than the broader market. Comparatively, CVRx has a beta of 0.81, suggesting that its share price is 19% less volatile than the broader market.

94.3% of TELA Bio shares are held by institutional investors. Comparatively, 75.3% of CVRx shares are held by institutional investors. 5.1% of TELA Bio shares are held by company insiders. Comparatively, 16.6% of CVRx shares are held by company insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a company is poised for long-term growth.

Summary

TELA Bio beats CVRx on 11 of the 17 factors compared between the two stocks.

How does TELA Bio compare to Avita Medical?

Avita Medical (NASDAQ:RCEL) and TELA Bio (NASDAQ:TELA) are both small-cap healthcare companies, but which is the superior investment? We will compare the two businesses based on the strength of their analyst recommendations, media sentiment, dividends, profitability, valuation, earnings, risk and institutional ownership.

27.7% of Avita Medical shares are held by institutional investors. Comparatively, 94.3% of TELA Bio shares are held by institutional investors. 2.2% of Avita Medical shares are held by company insiders. Comparatively, 5.1% of TELA Bio shares are held by company insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a company is poised for long-term growth.

Avita Medical presently has a consensus price target of $7.25, indicating a potential upside of 52.63%. TELA Bio has a consensus price target of $2.20, indicating a potential upside of 155.81%. Given TELA Bio's higher possible upside, analysts clearly believe TELA Bio is more favorable than Avita Medical.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Avita Medical	1 Sell rating(s)	2 Hold rating(s)	4 Buy rating(s)	0 Strong Buy rating(s)	2.43
TELA Bio	1 Sell rating(s)	1 Hold rating(s)	3 Buy rating(s)	0 Strong Buy rating(s)	2.40

Avita Medical has a beta of 1.86, indicating that its share price is 86% more volatile than the broader market. Comparatively, TELA Bio has a beta of 1.34, indicating that its share price is 34% more volatile than the broader market.

TELA Bio has higher revenue and earnings than Avita Medical. Avita Medical is trading at a lower price-to-earnings ratio than TELA Bio, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Avita Medical	$72.35M	2.02	-$48.59M	-$1.57	N/A
TELA Bio	$80.81M	0.48	-$38.83M	-$0.79	N/A

In the previous week, TELA Bio had 1 more articles in the media than Avita Medical. MarketBeat recorded 5 mentions for TELA Bio and 4 mentions for Avita Medical. TELA Bio's average media sentiment score of 0.46 beat Avita Medical's score of 0.00 indicating that TELA Bio is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Avita Medical	0 Very Positive mention(s)	0 Positive mention(s)	3 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral
TELA Bio	1 Very Positive mention(s)	1 Positive mention(s)	3 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral

TELA Bio has a net margin of -49.30% compared to Avita Medical's net margin of -62.67%. Avita Medical's return on equity of 0.00% beat TELA Bio's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Avita Medical	-62.67%	N/A	-78.92%
TELA Bio	-49.30%	-1,320.81%	-55.83%

Summary

TELA Bio beats Avita Medical on 11 of the 16 factors compared between the two stocks.

How does TELA Bio compare to Microbot Medical?

TELA Bio (NASDAQ:TELA) and Microbot Medical (NASDAQ:MBOT) are both small-cap healthcare companies, but which is the superior business? We will contrast the two companies based on the strength of their dividends, analyst recommendations, risk, valuation, media sentiment, institutional ownership, earnings and profitability.

TELA Bio currently has a consensus target price of $2.20, suggesting a potential upside of 155.81%. Microbot Medical has a consensus target price of $6.63, suggesting a potential upside of 268.06%. Given Microbot Medical's stronger consensus rating and higher probable upside, analysts clearly believe Microbot Medical is more favorable than TELA Bio.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
TELA Bio	1 Sell rating(s)	1 Hold rating(s)	3 Buy rating(s)	0 Strong Buy rating(s)	2.40
Microbot Medical	1 Sell rating(s)	0 Hold rating(s)	2 Buy rating(s)	2 Strong Buy rating(s)	3.00

94.3% of TELA Bio shares are held by institutional investors. Comparatively, 16.3% of Microbot Medical shares are held by institutional investors. 5.1% of TELA Bio shares are held by company insiders. Comparatively, 4.7% of Microbot Medical shares are held by company insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a stock is poised for long-term growth.

In the previous week, TELA Bio had 3 more articles in the media than Microbot Medical. MarketBeat recorded 5 mentions for TELA Bio and 2 mentions for Microbot Medical. Microbot Medical's average media sentiment score of 0.52 beat TELA Bio's score of 0.46 indicating that Microbot Medical is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
TELA Bio	1 Very Positive mention(s)	1 Positive mention(s)	3 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral
Microbot Medical	1 Very Positive mention(s)	0 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

Microbot Medical has a net margin of 0.00% compared to TELA Bio's net margin of -49.30%. Microbot Medical's return on equity of -21.84% beat TELA Bio's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
TELA Bio	-49.30%	-1,320.81%	-55.83%
Microbot Medical	N/A	-21.84%	-20.71%

TELA Bio has a beta of 1.34, meaning that its share price is 34% more volatile than the broader market. Comparatively, Microbot Medical has a beta of 1.06, meaning that its share price is 6% more volatile than the broader market.

Microbot Medical has lower revenue, but higher earnings than TELA Bio. Microbot Medical is trading at a lower price-to-earnings ratio than TELA Bio, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
TELA Bio	$80.81M	0.48	-$38.83M	-$0.79	N/A
Microbot Medical	N/A	N/A	-$13.14M	-$0.26	N/A

Summary

Microbot Medical beats TELA Bio on 9 of the 16 factors compared between the two stocks.

Get TELA Bio News Delivered to You Automatically

Subscribe Now

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding TELA and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.

TELA vs. The Competition

Export

Metric	TELA Bio	Healthcare Equipment & Supplies Industry	Healthcare Sector	NASDAQ Exchange
Market Cap	$38.50M	$5.72B	$6.92B	$12.85B
Dividend Yield	N/A	1.78%	2.60%	9.78%
P/E Ratio	-1.09	24.68	281.14	25.44
Price / Sales	0.48	58.72	575.40	80.57
Price / Cash	N/A	32.67	71.79	50.79
Price / Book	5.38	6.02	12.86	6.06
Net Income	-$38.83M	$152.55M	$3.49B	$348.34M
7 Day Performance	21.16%	3.20%	2.60%	3.00%
1 Month Performance	9.37%	-1.86%	-2.67%	-3.07%
1 Year Performance	-49.41%	8.83%	75.98%	20.68%

TELA Bio Competitors List

Export

Company	MarketRank	Share Price	Analysts' Price Target	1Y Price Performance	Market Cap	Revenue	P/E Ratio	Employee Count	Indicator(s)
TELA TELA Bio	3.14 of 5 stars	$0.86 -6.0%	$2.20 +155.8%	-50.5%	$38.50M	$80.81M	N/A	120	News Coverage Upcoming Earnings Gap Up
OWLT Owlet	2.2956 of 5 stars	$5.41 -0.4%	$15.00 +177.3%	-18.3%	$157.36M	$105.70M	N/A	106	Upcoming Earnings
STIM Neuronetics	3.4398 of 5 stars	$2.23 +3.0%	$4.00 +79.8%	-48.4%	$154.84M	$149.16M	N/A	180	Upcoming Earnings
CVRX CVRx	1.7041 of 5 stars	$5.55 +0.8%	$11.50 +107.4%	-17.9%	$147.11M	$56.65M	N/A	160	Analyst Forecast
RCEL Avita Medical	2.8561 of 5 stars	$4.73 +2.3%	$7.25 +53.4%	-15.3%	$145.47M	$71.61M	N/A	130

Related Companies and Tools

Related Companies

Top 10 Stock Comparisons

This page (NASDAQ:TELA) was last updated on 8/6/2026 by MarketBeat.com Staff.

From Our Partners

Unlock superior investment research and tools.

Get MarketBeat All Access

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

TELA Bio (TELA) Competitors

TELA vs. OWLT, STIM, CVRX, RCEL, and MBOT

How does TELA Bio compare to Owlet?

Summary

How does TELA Bio compare to Neuronetics?

Summary

How does TELA Bio compare to CVRx?

Summary

How does TELA Bio compare to Avita Medical?

Summary

How does TELA Bio compare to Microbot Medical?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

TELA vs. The Competition

TELA Bio Competitors List

Related Companies and Tools

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info

TELA Bio (TELA) Competitors

TELA vs. OWLT, STIM, CVRX, RCEL, and MBOT

How does TELA Bio compare to Owlet?

Do institutionals and insiders believe in TELA or OWLT?

Is TELA or OWLT more profitable?

Does the media refer more to TELA or OWLT?

Which has more volatility & risk, TELA or OWLT?

Do analysts prefer TELA or OWLT?

Which has higher earnings & valuation, TELA or OWLT?

Summary

How does TELA Bio compare to Neuronetics?

Which has more volatility and risk, TELA or STIM?

Which has preferable earnings and valuation, TELA or STIM?

Does the media prefer TELA or STIM?

Is TELA or STIM more profitable?

Do institutionals & insiders believe in TELA or STIM?

Do analysts rate TELA or STIM?

Summary

How does TELA Bio compare to CVRx?

Do analysts rate TELA or CVRX?

Which has stronger valuation and earnings, TELA or CVRX?

Does the media prefer TELA or CVRX?

Is TELA or CVRX more profitable?

Which has more risk & volatility, TELA or CVRX?

Do insiders & institutionals believe in TELA or CVRX?

Summary

How does TELA Bio compare to Avita Medical?

Do insiders and institutionals have more ownership in RCEL or TELA?

Do analysts recommend RCEL or TELA?

Which has more volatility and risk, RCEL or TELA?

Which has higher earnings and valuation, RCEL or TELA?

Does the media favor RCEL or TELA?

Is RCEL or TELA more profitable?

Summary

How does TELA Bio compare to Microbot Medical?

Do analysts prefer TELA or MBOT?

Do institutionals & insiders hold more shares of TELA or MBOT?

Does the media refer more to TELA or MBOT?

Is TELA or MBOT more profitable?

Which has more risk & volatility, TELA or MBOT?

Which has better earnings & valuation, TELA or MBOT?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

TELA vs. The Competition

TELA Bio Competitors List

Related Companies and Tools

MarketBeat All Access Features

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools